Indication
Sepsis-Induced Coagulopathy
1 clinical trial
2 products
Clinical trial
Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy: a Multicenter Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-10-01
Product
NafamostatProduct
5% Glucose